Real-world evaluation of glucose-lowering therapies and the use of weight-adjusted variable rate intravenous insulin infusion in the management of hyperglycaemia in patients with acute coronary syndrome (REGULATE-ACS)

Alexandros Leonidas Liarakos,Patrick Tran,Michelle Keegan,Tim Robbins,Nadia Chaudhari,Narasimha Murthy,Harpal Randeva,Nitin Narayan Gholap

International Journal of Cardiology（2022）

引用 1|浏览5

暂无评分

摘要

This real-world analysis provides further support of efficacy, safety, and feasibility of a modified, weight-adjusted VRIII in managing acute hyperglycaemia in ACS. Despite established cardio-protective benefits of novel glucose-lowering therapies, <1/3 of eligible patients received such agents pre-discharge, demanding further research and awareness.

查看译文

关键词

Hyperglycaemia,Acute coronary syndromes,Diabetes,Variable rate intravenous insulin infusion,Sodium-glucose co-transporter-2 inhibitor (SGLT-2 inhibitor),Glucagon-like peptide-1 receptor agonist (GLP1-RA)

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要